Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma
- 31 July 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (8) , 1243-1249
- https://doi.org/10.1016/s0959-8049(97)00095-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma—A report from the German Cooperative Pediatric Liver Tumor Study HB-89Journal of Pediatric Surgery, 1995
- Clinico-pathological criteria with prognostic relevance in hepatoblastomaEuropean Journal Of Cancer, 1994
- Hepatoblastoma — a bit of a success story?European Journal Of Cancer, 1994
- Chemotherapy can convert unresectable hepatoblastomaJournal of Pediatric Surgery, 1992
- The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapyJournal of Pediatric Surgery, 1991
- Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinomaCancer, 1989
- Hepatoblastoma and hepatocarcinoma in children: Analysis of a series of 29 casesJournal of Pediatric Surgery, 1986
- Adriamycin and cisplatin for hepatoblastomaCancer, 1985
- Preoperative chemotherapy for unresectable primary hepatic malignancies in childrenCancer, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958